In this issue:
Radiotherapy is an essential component of treatment in early HL
Nivolumab for newly diagnosed advanced-stage cHL
RAPID shows prognostic utility of PET score of 5
Loss of lifetime in Nordic cHL patients
Risk of colorectal cancer in HL survivors
Long-term benefit to eBEACOPP and consolidation radiotherapy in advanced disease
Pregnancies in long-term survivors of HL
Active surveillance for NLPHL
Brentuximab vedotin combination regimen for non-bulky cHL
Two year results from KEYNOTE-087
Please login below to download this issue (PDF)